E-cigarettes: A framework for comparative history and policy.

Australia E-cigarettes England United States history policy

Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
11 Mar 2024
Historique:
received: 17 10 2023
accepted: 31 01 2024
medline: 12 3 2024
pubmed: 12 3 2024
entrez: 11 3 2024
Statut: aheadofprint

Résumé

England, Australia and the United States have approached the regulation of e-cigarettes in very different ways, yet all three countries have appealed to the concept of evidence as underpinning policy responses. We compared these policy responses using a combination of the methodologies of historians and policy scientists in order to elucidate the factors that had influenced policy in each country. Each country's evidence and values intersected in different ways, producing very different responses within specific national contexts and histories. Our analysis accordingly emphasized the historical precursors of the policy issues raised by e-cigarettes and placed the policy debate within the context of regulatory bodies and the networks of researchers and advocates who influenced policy. Issues also of importance were the nature of the state; political context; the pre-history of nicotine for smoking cessation; the role of activism and its links with government; the influence of harm reduction ideas from drugs and HIV; and finally, whom policy was perceived to benefit. In the United Kingdom, based on this pre-history of the smoking issue, it was the existing smoker, while in the United States and Australia, protecting children and adolescents has played a central role. Structural and historical factors appear to underpin differences in e-cigarette policy development in England, Australia and the United States.

Sections du résumé

BACKGROUND BACKGROUND
England, Australia and the United States have approached the regulation of e-cigarettes in very different ways, yet all three countries have appealed to the concept of evidence as underpinning policy responses. We compared these policy responses using a combination of the methodologies of historians and policy scientists in order to elucidate the factors that had influenced policy in each country.
ARGUMENT/ANALYSIS UNASSIGNED
Each country's evidence and values intersected in different ways, producing very different responses within specific national contexts and histories. Our analysis accordingly emphasized the historical precursors of the policy issues raised by e-cigarettes and placed the policy debate within the context of regulatory bodies and the networks of researchers and advocates who influenced policy. Issues also of importance were the nature of the state; political context; the pre-history of nicotine for smoking cessation; the role of activism and its links with government; the influence of harm reduction ideas from drugs and HIV; and finally, whom policy was perceived to benefit. In the United Kingdom, based on this pre-history of the smoking issue, it was the existing smoker, while in the United States and Australia, protecting children and adolescents has played a central role.
CONCLUSIONS CONCLUSIONS
Structural and historical factors appear to underpin differences in e-cigarette policy development in England, Australia and the United States.

Identifiants

pubmed: 38467572
doi: 10.1111/add.16462
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 209524/Z/17/ZE
Pays : United Kingdom

Informations de copyright

© 2024 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Références

Berridge V, Bayer R, Fairchild AL, Hall W. E-cigarettes and the Comparative Politics of Harm Reduction. History, Evidence and Policy Basingstoke, UK: Palgrave Macmillan; 2023.
Berridge V, Strong P. AIDS and Contemporary History. Cambridge, UK: Cambridge University Press; 1993.
Fairchild AL, Colgrove J. Out of the ashes: the life, death, and rebirth of the ‘safer’ cigarette in the United States. Am J Public Health. 2004;94:198-204.
Bayer R, Colgrove J. Children and bystanders first: the ethics and politics of tobacco control in the United States. In: Feldman E, Bayer R, editors. Unfiltered: Conflicts Over Tobacco Policy and Public Health Boston, MA: Harvard University Press; 2004. p. 8-37.
National Academies of Sciences, Engineering, and Medicine. Public health consequences of E-cigarettes. National Academies Press 2018:11. https://doi.org/10.17226/24952
Roxon N. Plain packaging special issue. QUT Law Review. 2017;17:i-iii.
Australian Story. Roxon’s family motivation for plain-packaging push. ABC. 2012. Available at: https://www.abc.net.au/news/2012-08-27/nicola-roxon-on-australian-story/4225972 Accessed 16 Jan 2024.
National Preventative Health Taskforce. Australia: the Healthiest Country by 2020 Canberra, ACT: Commonwealth of Australia; 2009.
Chapman S, Wakefield MA. Large-scale unassisted smoking cessation over 50 years: lessons from history for endgame planning in tobacco control. Tob Control. 2013;22:i33-i35.
Chapman S, MacKenzie R. The global research neglect of unassisted smoking cessation: causes and consequences. PLoS Med. 2010;7:e1000216.
Berridge V. Outlier or pioneer? The development of policy on E-cigarettes in England. In: Berridge V, Bayer R, Fairchild AL, Hall W, editorsE-cigarettes and the Comparative Politics of Harm Reduction. History, Evidence and Policy Basingstoke, UK: Palgrave Macmillan; 2023. p. 34-35.
Centers for Disease Control and Prevention. E-cigarettes: an Emerging Public Health Challenge. 2015. Available at: https://www.cdc.gov/grand-rounds/pp/2015/20151020-e-cigarettes.html Accessed 16 Jan 2023.
Gartner C, Bromberg M. One does not simply sell e-cigarettes in Australia: an overview of Australian e-cigarete regulations. In: Gruszczynski L, editor. The Regulation of E-cigarettes: International, European and National Challenges. Cheltenham, UK: Elgar Online; 2019. https://doi.org/10.4337/9781788970464.00021
Berridge V. Marketing health: Smoking and the Discourse of Public Health in Britain, 1945-2000 Oxford, UK: Oxford University Press; 2007.
Kandel DB, Wu P, Davies M. Maternal smoking during pregnancy and smoking by adolescent daughters. Am J Public Health. 1994;84:1407-1413.
Kandel E, Kandel D. A molecular basis for nicotine as a gateway drug. N Engl J Med. 2018;371:932-943.
Bayer R, Fairchild AL. The genesis of public health ethics. Bioethics. 2004;18:473-492.
Erku DA, Kisely S, Morphett K, Steadman KJ, Gartner C. Framing and scientific uncertainty in nicotine vaping product regulation: an examination of competing narratives among health and medical organisations in the UK, Australia and New Zealand. Int J Drug Policy. 2020;78:102699.
Hall W, Gartner C, Morphett K. How has the brain disease model of addiction contributed to tobacco control? Drug Alcohol Depend. 2023;253:111033.
Fairchild AL, Lee JS, Bayer R, Curran J. E-cigarettes and the harm-reduction continuum. N Engl J Med. 2018;378:216-219.
Erku DA, Morphett K, Steadman JK, Gartner C. Policy debates regarding nicotine vaping products in Australia: a qualitative analysis of submissions to a government inquiry from health and medical organisations. Int J Environ Res Public Health. 2019;16:4555.
Wakefield MA, Durkin S, Spittal MJ, Siahpush M, Scollo M, Simpson JA, et al. Impact of tobacco control policies and mass media campaigns on monthly adult smoking prevalence. Am J Public Health. 2008;98:1443-1450.
House of Representatives Standing Committee on Health, Aged Care, and Sport. Report on the inquiry into the use and marketing of electronic cigarettes and personal vaporisers in Australia. Commonwealth of Australia, 2018. Available at: http://parlinfo.aph.gov.au/parlInfo/download/committees/reportrep/024115/toc_pdf/ReportontheInquiryintotheUseandMarketingofElectronicCigarettesandPersonalVaporisersinAustralia.pdf;fileType=application%2Fpdf Accessed 16 Jan 2024.
Select Senate Committee on Tobacco Harm Reduction. Commitee report by the majority. 2020. Available at: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Tobacco_Harm_Reduction/TobaccoHarmReduction/Report Accessed 16 Jan 2024.
Berridge V. AIDS in the UK. The making of policy, 1981-1996 Oxford, UK: Oxford University Press; 1996.
Gottlieb S, Zeller M. A nicotine-focused framework for public health. N Engl J Med. 2017;77:1111-1114.
Commonwealth of Australia. National Drug Strategy, 2017. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/55E4796388E9EDE5CA25808F00035035/$File/National-Drug-Strategy-2017-2026.pdf Accessed 16 Jan 2024.
Moore M, McKee M, Daube M. Harm reduction and e-cigarettes: distorting the approach. J Public Health Policy. 2016;37:403-410.
Food and Drug Administration (FDA). Facts about E-cigarettes. Available at: https://www.fda.gov/news-events/rumor-control/facts-about-e-cigarettes Accessed 1 Dec 2023.
Tobacco Education Resource Library. FDA authorized E-cigarette products. Available at: https://digitalmedia.hhs.gov/tobacco/print_materials/CTP-250?utm_source=CTPTwitter&utm_medium=social&utm_campaign=ctp-terl Accessed 1 Dec 2023.

Auteurs

Virginia Berridge (V)

Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Amy Lauren Fairchild (AL)

Syracuse University, Syracuse, NY, USA.

Kylie Morphett (K)

School of Public Health, The University of Queensland, Herston, QLD, Australia.

Coral Gartner (C)

School of Public Health, The University of Queensland, Herston, QLD, Australia.

Wayne Hall (W)

Centre for Youth Substance Abuse Research, The University of Queensland, Herston, QLD, Australia.

Ronald Bayer (R)

Mailman School of Public Health, Columbia University, New York, NY, USA.

Classifications MeSH